Rik Eijgelshoven

Reporting to the regional Market Access and Corporate Affairs department. Single point of contact for health insurances, medical examiners, pharmaceutical whole salers, physician networks, hospital pharmacies, buying groups and other strategic stakeholders in the Swiss Healthcare System. Member of relevant brand teams. Aiming for mutual beneficial collaborations to sustainably improve the quality of life of our patients.

X-functional project team lead to setup a new company-wide strategy. The team builds strong and mutual beneficial relationships with new stakeholders like KOLs, relevant physicians in private praxis and other strategic stakeholders (e.g. Payers, Regulatory Bodies, etc.). The team aims to increase demand by illustrating, developing and combining the medical and economic value of Roche’s diagnostic solutions and make affordable personalized healthcare available to as much patients as possible.

Develop and execute the access and pricing strategies for the launch of brands/indications. Build compelling value propositions and stakeholder models/materials based on insights and data-driven value demonstration. Strategic thought leader and expert contact for all disease area/brand related access aspects. Contribute in country brand teams as well as broader collaboration with BMS units and functions.

Negotiating innovative services and strategic approaches with key stakeholders in the pharmaceutical and consumer health care industry to support and grow their business. Discussing tailor made complex projects and solutions to improve productivity and sales force effectiveness in order to make high quality medical care available to more and more people around the world.

Negotiating complex win-win-solutions with high level customers and key stakeholders are considered key for success. Position set in a complex matrix reporting structure requiring active alignment of the key account strategy with the regional sales teams and national marketing requirements at the same time. Tailor-made projects have been successfully implemented and led to sustainable growth of MSD’s business in Switzerland.

Responsible for the Sales of Arcoxia®, Singulair®, Januvia®/Janumet®, Fosamax®/Fosavance® und Maxalt® in the region of Luzern, Central Part of CH.

Responsible for the development of soft gelatin capsules with new pharmaceutical formulations.

Responsible for the release of manufactured, packed and laboratory tested pharmaceutical products.